Parr McKnight Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.72M Buy
6,216
+5,091
+453% +$5.16M 0.75% 41
2025
Q4
$1.21M Sell
1,125
-67
-6% -$64.1K 0.16% 143
2025
Q3
$909K Sell
1,192
-3,490
-75% -$2.6M 0.12% 166
2025
Q2
$3.65M Sell
4,682
-83
-2% -$64.5K 0.5% 65
2025
Q1
$3.94M Sell
4,765
-1,347
-22% -$1.12M 0.57% 50
2024
Q4
$4.72M Buy
+6,112
New +$5.06M 0.68% 38

Other funds holding LLY

Parr McKnight Wealth Management Group's LLY Position: Q1 2026 in Review

Parr McKnight Wealth Management Group increased its Eli Lilly (LLY) stake by 453% in Q1 2026, buying an estimated $5.16M and bringing the position to 6,216 shares worth $5.72M. The position accounts for 0.75% of the portfolio, ranked #41.

Parr McKnight Wealth Management Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Parr McKnight Wealth Management Group held 6,216 shares of Eli Lilly worth $5.72M as of Q1 2026.
  • Parr McKnight Wealth Management Group bought 5,091 Eli Lilly shares in Q1 2026, an estimated $5.16M.
  • Eli Lilly made up 0.75% of Parr McKnight Wealth Management Group's portfolio in Q1 2026, its #41 holding.
  • Parr McKnight Wealth Management Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.